ecogacrinnews2

September 26, 2022

Now Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancer

Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer
September 26, 2022

Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer

These five clinical trials are exploring possible new treatments for adults with head and neck cancers. These cancers can involve the mouth, throat, voice box (larynx)—or, much more rarely, the nose/sinuses or saliva glands
June 28, 2022

Unconscious bias among physicians creates obstacles to genetic counseling and testing for Black women with breast cancer

A nationwide survey found that doctors’ beliefs and practices regarding genetic counseling and testing varied by race
June 28, 2022

Now Enrolling: The EA9213 clinical trial is testing a new treatment for patients with T-cell acute lymphoblastic leukemia

This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment